Alesco Advisors LLC Pfizer Inc Transaction History

Alesco Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $669 - $871	17 Added 0.3%	5,617 $229,000
Q4 2022 Jan 26, 2023	SELL	$41.75 - $54.5 $4,843 - $6,322	-116 Reduced 2.03%	5,600 $0
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $74,392 - $90,814	1,700 Added 42.33%	5,716 $250,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $1,395 - $1,655	-30 Reduced 0.74%	4,016 $211,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $9,333 - $11,564	-204 Reduced 4.8%	4,046 $209,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $175,610 - $260,312	4,250 New	4,250 $251,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $212,841 - $275,993	-6,551 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $242,255 - $271,997	6,551 New	6,551 $284,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $400,217 - $424,644	-12,033 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $373,023 - $410,926	12,033	12,033 $430,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Alesco Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alesco Advisors LLC with notifications on news.